Using placental growth factor to predict preeclampsia risk in pregnant women with sickle cell disease
In pregnant women with sickle cell disease, the risk of developing early-onset preeclampsia can be determined by measuring…
HER2 and CD24 emerge as promising radiotheranostic targets in endometrial cancer
Two molecular targets-human epidermal growth factor 2 (HER2) and cluster of differentiation 24 (CD24)-are highly promising candidates for…
Heparanase 2 emerges as key protector of blood vessel integrity
An international research team led by MDI Biological Laboratory President Hermann Haller, M.D. and postdoctoral researcher Yannic Becker,…
UiPath Continues Its Momentum With AI-Powered Automation Growth
UiPath PATH continues to drive value in 2025 through its innovative AI-powered enterprise automation platform, a single defining…